Carlos Camozzi

Chair, Rare & Orphan Scientific Advisory Board

Dr. Carlos Camozzi is an experienced chief executive and corporate governance in the biopharmaceuticals and health technology with over 30 years c-level expertise/experience of the orphan drugs, gene- and cell-therapy, biopharma and medical devices industry.

Carlos has generated innovative solutions to the evaluation, design and the execution of non-clinical, translational, and clinical development projects for several orphan drugs, paediatric and oncology clinical trials. He successfully led several clinical development programs, regulatory interactions, consultations, submissions and approvals of orphan drug applications (ODA), paediatric investigational plans (PIP) and marketing authorisations applications (MAA) by both the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA).

Get started with us today

Discover what’s possible when you have the right partner. Get in touch to see how we can support you.

Other board members

Got a question? Get in Touch or Submit an RFI/RFP


Our team is on hand to answer any questions you might have relating to the work we do at Simbec-Orion. Just fill in the form below, making sure to tick the boxes that apply, and we’ll respond as quickly as we can.

Looking to volunteer for a clinical trial?

Visit our dedicated volunteer website here, or email [email protected]

Follow us on Social Media

Send us a message, we’ll respond as quickly as possible

Complete the form below, and we’ll get back to you as soon as possible regarding your query.

Name(Required)
Opt In Emails